Why the study?
It is unknown how mechanical circulatory support has affected the characteristics and post-heart transplantation outcomes of patients with hypertrophic cardiomyopathy.
How do characteristics and post-heart transplantation outcomes of patients with hypertrophic cardiomyopathy compare across different eras of mechanical circulatory support and against other cardiomyopathies?
How do characteristics and post-heart transplantation outcomes of patients with hypertrophic cardiomyopathy compare across different eras of mechanical circulatory support and against other cardiomyopathies?
Answers are grounded in this paper and cite their sources.
Despite increased acuity and use of mechanical circulatory support prior to transplant, patients with hypertrophic cardiomyopathy continue to have favorable post-transplant survival comparable to nonischemic cardiomyopathy.
Mechanical circulatory support has emerged as a vital therapeutic modality for patients awaiting heart transplantation (HT). However, it is unknown how it affected the characteristics and post-HT outcomes of patients with hypertrophic cardiomyopathy (HCM). This retrospective cohort study analyzed adult HT recipients from the International Society for Heart and Lung Transplantation registry (1998-2017). Two equal-duration eras were defined: era 1 1998-2007 and era 2 2008-2017. Patients with HCM were compared across the two eras (n 1 = 742 and n 2 = 1,211) and within each era, they were contrasted with individuals with nonischemic (NICM) (n 1 = 15,964 and n 2 = 20,394) and ischemic cardiomyopathy (ICM) (n 1 = 14,140 and n 2 = 12,986). Across eras, the number of HTs among patients with HCM increased by 63%. The rate of recipients with HCM in the intensive care unit (ICU) supported with intra-aortic balloon pump (IABP) increased, yet their pre-HT functional status improved, and 5 year post-HT survival remained unchanged and favorable. In era 2, at the time of HT, patients with HCM were more frequently than their NICM and ICM counterparts in the ICU and supported with inotropes. In the same era, 1 and 5 year survival were more favorable in HCM compared to ICM and comparable to NICM.
No takes yet. Share an insight, caveat, or question.
Mazur et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: